Wedemark, Germany

Stephan Von Hoersten

This inventor holds 5 USPTO granted patents. Top assignees: Probiodrug Ag, Other. Active years: 2006-2012.


Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Neuropsychiatric Treatment by Stephan Von Hoersten

Introduction

Stephan Von Hoersten is a notable inventor based in Wedemark, Germany. He has made significant contributions to the field of neuropsychiatric treatment, holding a total of 5 patents. His work focuses on innovative methods for treating various mental health conditions, including schizophrenia and anxiety.

Latest Patents

Among his latest patents, Von Hoersten has developed dipeptidyl peptidase IV inhibitors aimed at treating schizophrenia and depression. This method involves therapeutically treating individuals for psychosomatic, depressive, and neuropsychiatric diseases. The administration of a suitable DP IV inhibitor reduces the activity of the enzyme dipeptidyl peptidase in the brain, leading to a decrease in the degradation of neuropeptide Y. This results in enhanced stability of neuronal NPY, which facilitates various neurological effects, including antidepressive and anxiolytic properties. Additionally, he has patented a similar method specifically targeting anxiety, further showcasing his commitment to advancing mental health treatments.

Career Highlights

Throughout his career, Von Hoersten has worked with various companies, including Probiodrug AG. His innovative approaches have positioned him as a key figure in the development of therapeutic methods for mental health disorders.

Collaborations

He has collaborated with notable professionals in the field, including Hans-Ulrich Demuth and Torsten Hoffmann. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Stephan Von Hoersten's contributions to neuropsychiatric treatment through his innovative patents highlight his dedication to improving mental health care. His work continues to influence the field and offers hope for effective treatments for various psychological conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…